These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9558605)

  • 21. Respiratory fluoroquinolones: differences in the details.
    Mandell LA; Iannini PB; Tillotson GS
    Clin Infect Dis; 2004 May; 38(9):1331-2; author reply 1332-3. PubMed ID: 15127351
    [No Abstract]   [Full Text] [Related]  

  • 22. Community-acquired bacterial respiratory tract infections.
    Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
    J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.
    Nicolau DP
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S381-8. PubMed ID: 15603247
    [No Abstract]   [Full Text] [Related]  

  • 24. Doxycycline in community acquired respiratory infections--a perspective of 1990's.
    Mahashur AA; Jaguste V
    J Assoc Physicians India; 1999 Mar; 47(3):326-31. PubMed ID: 10999130
    [No Abstract]   [Full Text] [Related]  

  • 25. The continuing challenge of lower respiratory tract infections.
    Moellering RC
    Clin Infect Dis; 2004 May; 38 Suppl 4():S319-21. PubMed ID: 15127364
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bacteriology in community-acquired respiratory pathology].
    Weber P
    Presse Med; 1998 Mar; 27(11):546-8. PubMed ID: 9767971
    [No Abstract]   [Full Text] [Related]  

  • 27. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of newer fluoroquinolones in lower respiratory tract infections.
    Lode H; Allewelt M
    J Antimicrob Chemother; 2002 May; 49(5):709-12. PubMed ID: 12003962
    [No Abstract]   [Full Text] [Related]  

  • 29. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center.
    Hung MN; Chen SY; Wang JL; Chang SC; Hsueh PR; Liao CH; Chen YC
    J Microbiol Immunol Infect; 2005 Dec; 38(6):436-43. PubMed ID: 16341345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
    Pell DM
    Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
    Doern GV
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
    Liam CK; Aziah AM; Lim KH; Wong CM
    Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.
    Ambrose PG; Bhavnani SM; Rubino CM; Louie A; Gumbo T; Forrest A; Drusano GL
    Clin Infect Dis; 2007 Jan; 44(1):79-86. PubMed ID: 17143821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Levofloxacin for prevalent infections in primary care medicine].
    Redondo Sánchez J
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():29-33. PubMed ID: 10563108
    [No Abstract]   [Full Text] [Related]  

  • 35. Methicillin-resistant Staphylococcus aureus bacteremia and pneumonia.
    Ganesan A
    Dis Mon; 2008 Dec; 54(12):787-92. PubMed ID: 18996281
    [No Abstract]   [Full Text] [Related]  

  • 36. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Sollet JP
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S113-4. PubMed ID: 16904296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods.
    Gonzales R; Bartlett JG; Besser RE; Cooper RJ; Hickner JM; Hoffman JR; Sande MA
    Ann Emerg Med; 2001 Jun; 37(6):690-7. PubMed ID: 11385342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.
    Principi N; Esposito S; Blasi F; Allegra L;
    Clin Infect Dis; 2001 May; 32(9):1281-9. PubMed ID: 11303262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to the effective management of respiratory tract infections in the community.
    Saginur R
    Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic therapy for lower tract infections in children].
    Ovetchkine P
    Arch Pediatr; 2004 Oct; 11(10):1277-81. PubMed ID: 15475293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.